Filament Health Logo
About Us
Technology
Why Natural?
Drug Development
Drug Access & Clinical Trials
Investors
News
Filament Logo
Sign up for our newsletter
I am interested in
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
About Us
Technology
Why Natural?
Drug Development
Drug Access & Clinical Trials
Investors
News
Twitter icon
LinkedIn icon
Instagram icon
YouTube icon
Privacy Policy

Recent News

Filament CEO: Natural Psilocybin Is the Logical Option, So Why Is the Industry Stuck on Synthetic?

ReMind Media

September 28, 2022
News >
Recent News
>
Filament CEO: Natural Psilocybin Is the Logical Option, So Why Is the Industry Stuck on Synthetic?
Share this post:
Twitter icon
LinkedIn icon
Sign up for our newsletter
Visit:
Filament CEO: Natural Psilocybin Is the Logical Option, So Why Is the Industry Stuck on Synthetic?
Read the full article

read more News

Press Release

Filament Health Corp. Announces Non-Brokered Private Placement Unit Offering Led By Negev Capital

September 29, 2023
Press Release

Filament Health And Jaguar Health Joint Venture Magdalena Biosciences Completes Import Of Coca Leaf From Peru

September 21, 2023
Press Release

Filament Health Enters Licensing Agreement With Reset Pharma

August 31, 2023

Sign up for our newsletter

I am interested in
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Sitemap
HomeAbout UsTechnologyWhy Natural?Drug DevelopmentDrug Access & Clinical TrialsInvestorsNews
Contact
210-4475 Wayburne Drive
Burnaby, BC  V5G 4X4
General InquiriesMedia InquiriesInvestor InquiriesCareers
Twitter icon
LinkedIn icon
Instagram icon
YouTube icon
Copyright © Filament Health. All rights reserved.
Privacy Policy